A Study To Confirm Efficacy and Safety of Terlipressin in HRS Type 1
Lay Description
This study is to confirm the efficacy and safety of intravenous terlipressin versus placebo in the treatment of adult subjects with hepatorenal syndrome (HRS) Type 1.
Category
- Family Health
- IRB Number
- 20170588HU
- NCT Number
- ct.gov registration not required
- Open to Enrollment
- No
Eligibility
- Eligible Ages
- Over 18 Years
- Eligible Genders
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
Exclusion Criteria
Study Design
Arm Groups
Study Contact
Diana Anzueto Guerra
(210) 567-5225
anzuetod@uthscsa.edu
Alice Gong
(210) 567-5227
gong@uthscsa.edu
Diana Anzueto Guerra
(210) 567-5225
anzuetod@uthscsa.edu
Principal Investigator
Alice Gong